Genetic Testing May Increase Fear of Recurrence
It is well known that fear of recurrence is a major issue in the cancer community, but can genetic test results outlining risk impact those feelings?
It is well known that fear of recurrence is a major issue in the cancer community, but can genetic test results outlining risk impact those feelings?
For this episode of “The Vitals,” we spoke with Maurade Gormley, CPNP, RN, assistant professor and post-doctoral fellow at the NYU Rory Myers College of Nursing. Her recent research analyzed how Oncotype DX genomic test results may increase fear of recurrence in breast cancer survivors.
PFS Significantly Improves With Dato-DXd in HR+, HER2- Metastatic Breast Cancer
October 25th 2023Patients with metastatic hormone receptor-positive breast cancer treated with datopotamab deruxtecan experienced a statistically significant and clinically meaningful improvement in progression-free survival.
